Vnitr Lek 2011, 57(4):378-380

Colorectal cancer and diabetes

Š. Svačina
III. interní klinika 1. lékařské fakulty UK a VFN Praha, přednosta prof. MUDr. Štěpán Svačina, DrSc., MBA

Colorectal carcinoma is a tumour with higher incidence in patients with type 2 diabetes and obesity. Recently, a slightly higher risk has also been shown in prediabetic states. The most important latest finding is that of a reduced risk in patients treated with metformin; there is a trend now to also prescribe metformin in patients with disturbed glucose tolerance or increased fasting glycaemia. Regular physical activity and reduced animal fat intake with increased intake of fruits and vegetables may help to prevent the disease. Pathogenesis may include changes to intestinal flora. The most important current preventive clinical measure is colonoscopy. Type 2 diabetes patients should be considered as a risk group and thus prevention should be targeted at these patients.

Keywords: metabolic syndrome; type 2 diabetes mellitus; colorectal cancer; prediabetes; metformin

Received: February 13, 2011; Published: April 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Svačina Š. Colorectal cancer and diabetes. Vnitr Lek. 2011;57(4):378-380.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Svačina Š et al. Metabolický syndrom. Praha: Triton 2006.
    2. Svačina Š. Nádory ledvin, močového měchýře a prostaty u obezity a diabetu. Vnitř Lék 2008; 54: 464-467. Go to PubMed...
    3. Svačina Š, Matoulek M, Svobodová Š et al. Nádory trávicího traktu a diabetes mellitus. Vnitř Lék 2004; 50: 386-391. Go to PubMed...
    4. Hjalgrim H, Frisch M, Ekbom A et al. Cancer and diabetes - a follow-up study of two population-based cohorts of diabetic patients. J Intern Med 1997; 241: 471-475. Go to original source... Go to PubMed...
    5. Jonasson JM, Ljung R, Talbäck M et al. Insulin glargine use and short-term incidence of malignancies - a population-based follow-up study in Sweden. Diabetologia 2009; 52: 1745-1754. Go to original source... Go to PubMed...
    6. Currie CJ, Poole CD, Gale EA. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia 2009; 52: 1766-1777. Go to original source... Go to PubMed...
    7. Hemkens LG, Grouven U, Bender R et al. Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study. Diabetologia 2009; 52: 1732-1744. Go to original source... Go to PubMed...
    8. Diabetologia 2010; 1. České vydání, výběr z časopisu.
    9. Giovannucci E, Harlan DM, Archer MC et al. Diabetes and cancer: a consensus report. Diabetes Care 2010; 33: 1674-1685. Go to original source... Go to PubMed...
    10. Garfinkel L. Overweight and cancer. Ann Intern Med 1985; 103: 1034-1036. Go to original source... Go to PubMed...
    11. Ford ES. Body mass index and colon cancer in a national sample of adult US men and women. Am J Epidemiol 1999; 150: 390-398. Go to original source... Go to PubMed...
    12. Hu FB, Giovannucci E. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst 1999; 91: 542-547. Go to original source... Go to PubMed...
    13. La Vecchia C, Negri E, Decarli A et al. Diabetes mellitus and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 1997; 6: 1007-1010.
    14. Meyerhardt JA, Catalano PJ, Haller DG et al. Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol 2003; 21: 433-440. Go to original source... Go to PubMed...
    15. Ren X, Zhang X, Zhang X et al. Type 2 diabetes mellitus associated with increased risk for colorectal cancer: evidence from an international ecological study and population-based risk analysis in China. Public Health 2009; 123: 540-544. Go to original source... Go to PubMed...
    16. Currie CJ, Poole CD, Gale EA. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia 2009; 52: 1766-1777. Go to original source... Go to PubMed...
    17. Zhou XH, Qiao Q, Zethelius B et al. DECODE Study Group. Diabetes, prediabetes and cancer mortality. Diabetologia 2010; 53: 1867-1876. Go to original source... Go to PubMed...
    18. Noh GY, Hwang DY, Choi YH et al. Effect of diabetes mellitus on outcomes of colorectal cancer. J Korean Soc Coloproctology 2010; 26: 424-428. Go to original source... Go to PubMed...
    19. Holcátová I, Svačina Š. Dieta v prevenci a léčbě nádorových onemocnění. In: Svačina Š (ed.). Klinická dietologie. Praha: Grada 2008: 265-277.
    20. Tlaskalová-Hogenová H, Stěpánková R, Kozáková H et al. The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cell Mol Immunol 2011; 8: 110-120. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.